Challenges in the Perioperative Localization in Secondary Hyperparathyroidism, a Case Report by Haj Hamad, Mohammed Mahmoud et al.
 International Journal of Sciences: 
Basic and Applied Research 
(IJSBAR) 
 
ISSN 2307-4531 
(Print & Online) 
 
http://gssrr.org/index.php?journal=JournalOfBasicAndApplied 
--------------------------------------------------------------------------------------------------------------------------- 
Challenges in the Perioperative Localization in Secondary 
Hyperparathyroidism, a Case Report 
Haj Hamad Ma, Suhaimi Sb*, Latar Nc, Aini Ad, Rohaizak Me  
 
a,b,c,eEndocrine and Breast Surgery Unit, Department of Surgery, UKM Medical Center, JalanYaacobLatif, 
Bandar TunRazak, Cheras,56000,  Kuala Lumpur, Malaysia. 
d Nuclear Medicine Unit, Department of Radiology, UKM Medical Center, JalanYaacobLatif, Bandar 
TunRazak, Cheras,56000,  Kuala Lumpur, Malaysia.  
aemail: haghamad@hotmail.com 
bemail: shahrun72.sn@gmail.com 
 
Abstract 
 
To detect hyperfunctioning glands, noninvasive procedures such as ultrasound, sestamibi scan, and magnetic 
resonance imaging (MRI) are widely available. Preoperative localization studies give important information and 
enable unilateral exploration or minimal invasive parathyroidectomy. Localization studies and parathyroid 
hormone assays have not clearly modified the conventional surgical approach of the disease. Controversy 
regarding the surgery to be favored, between subtotal parathyroidectomy and total parathyroidectomy with 
autotransplantation, continues against the background of relevant recurrence rates, persistent SHPT, and 
markedly increased complication rates in reoperation. We are presenting a case of 54-year-old male, on regular 
hemodialysis (HD) referred by his nephrologist for symptomatic hyperphosphatemia and osteoporosis. 
Phosphate binders and vitamin D failed to control the disease. Patient underwent neck exploration aiming for 
total parathyroidectomy, but during surgery we were able to find only the left inferior parathyroid gland. For the 
few months after the surgery, patient phosphate, iPTH and alkaline phosphatase still deranged. So, the decision 
was made to do preoperative localization study to confirm the presence and location of the remaining 3 
parathyroid gland before re-exploration of the neck. Ultrasonography, computerized tomography of the neck and 
thorax as well as sestamibi scan done. The results were inconclusive.  
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Re-exploration was performed only right and left superior parathyroid glands. Still unable to localize right 
inferior gland. Postoperatively, biochemical derangement started to improve slowly.  In conclusion; we can say 
that Noninvasive methods, such as ultrasound, sestamibi scan or MRI, are not always successful in localizing 
the hyperfunctioning parathyroid gland. Selective venous sampling (SVS) of PTH is an invasive method of 
localization that is used only rarely in comparison to noninvasive methods. Ultrasonography is an important, 
cost-effective diagnostic tool that is frequently used in combination with a sestamibi scan. 
Keywords: Secondary hyperparathyroidism; localization; neck exploration; parathyroidectomy. 
1. Introduction 
Hyperparathyroidism (HPT) is a clinical problem resulting in elevated levels of serum parathyroid hormone, and 
elevated levels of serum and urine calcium. Renal hyperparathyroidism, including secondary and tertiary forms, 
can be caused by renal failure. Supernumerary parathyroid glands in renal hyperparathyroidism are described in 
about 30% of the operated cases [1]. 
To detect hyperfunctioning glands, noninvasive procedures such as ultrasound, sestamibi scan, and magnetic 
resonance imaging (MRI) are widely available. Preoperative localization studies give important information and 
enable unilateral exploration or minimal invasive parathyroidectomy [2]. 
Localization studies and parathyroid hormone assays have not clearly modified the conventional surgical 
approach of the disease. Controversy regarding the surgery to be favored, between subtotal parathyroidectomy 
and total parathyroidectomy with autotransplantation, continues against the background of relevant recurrence 
rates, persistent SHPT, and markedly increased complication rates in reoperation [3]. 
Localization diagnosis often is considered unnecessary in secondary and 3HPT because patients will undergo a 
bilateral neck exploration. However, the treatment of SHPT consists of the removal of all hyperfunctioning 
parathyroid tissue; knowing that 15% of patients who receive continuous dialysis have an increased incidence of 
supernumerary (fifth or sixth) and ectopic glands, and aside from the fact that successful surgery will mainly 
depend on the availability of a highly skilled surgeons experienced in parathyroid surgery, clinicians are using 
more of these new localizations studies with improved accuracy to decrease the risk of missing some 
hyperfunctioning glands [4]. 
Localization options includes ultrasonography, screening and follow-up contribute to indication for surgery by 
estimating the size of enlarged glands. It has a reported sensitivity of 45-70%.[3]  CT and MRI Indicated when 
large glands are not found by US. Superior mediastinum, behind the trachea or esophagus or deep in the neck. 
Scintigraphy is a more accurate method.  Its sensitivity with thallium and technetium is only 75-80% [5]. 
123I/99mTc-Sestamibi subtraction with single photon- emission computed tomography (SPECT) have 
sensitivity up to 95% when double tracer 99mTc-pertechnetate/tetrofosmin and SPECT are combined. The 
sensitivity of sestamibiscintigraphy ranges from 64% to 88% for a single adenoma, but is just 44% for 
hyperplasia and 30% for double adenoma; the rate of false positives is about 15% [6]. 
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For Intra-operative localization: intravenous iPTH sampling, but it’s invasive and require rapid PTH assay. 
Also, intraoperative techniques (US, gamma-camera) also can be used [7]. 
2. Case summary 
We are presenting a case of 54-year-old male, who had been on regular hemodialysis (HD) for more than 9 
years for his ESRF. He was referred by his nephrologist for symptomatic Hyperphosphatemia, as he has 
generalized bone pain. Phosphate binders and vitamin D failed to control the disease. At time of presentation, 
there was evidence of bone turnover, with elevated alkaline phosphatase 365 U/L (normal 32 – 104 U/L) and 
generalized osteoporosis diagnosed by skeletal survey. His intact parathyroid hormone iPTH was 114.0 pmol/L 
(normal 1.3 - 7.6 pmol/L). Patient underwent neck exploration aiming for total parathyroidectomy, but during 
surgery we were able to find only the left inferior parathyroid gland, which was confirmed by histological 
examination later on. For the few months after the surgery, patient phosphate, iPTH and alkaline phosphatase 
still deranged. So, the decision was made to do preoperative localization study to confirm the presence and 
location of the remaining 3 parathyroid gland before re-exploration of the neck. Ultrasonography, computerized 
tomography of the neck and thorax as well as sestamibi scan done. The results were not concomitant to each 
other (Figure 1).  
 
Fig. 1. Summary of preoperative localization studies. 
In view of persistent biochemical derangement, despite inconclusive preoperative localization studies, a re-
exploration was performed, during which we was able to identify and remove both right and left superior 
parathyroid glands. Still unable to localize right inferior gland. However, iatrogenic injury to the left recurrent 
laryngeal nerve occurred. Postoperatively, biochemical derangement started to improve slowly.  
3. Discussion 
Parathyroidectomy is unsuccessful in 10–30% of uraemic patients operated on for secondary 
hyperparathyroidism. The main cause of surgical failure is incomplete identification of all parathyroid tissue. 
The total rate of surgical failure is much higher than that reported for   primary hyperparathyroidism, which is 
less than 8% in experienced hands. Surgical morbidity and mortality rates are also higher in patients with renal 
failure than in patients operated on for primary hyperparathyroidism [1]. 
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Few surgeons believe that preoperative imaging can improve the success rate of first surgery in uraemic 
patients, in whom all parathyroid glands should be searched for. A few investigators have routinely combined 
computed tomography, thallium-201 scanning, and ultrasonography, but the sensitivity for enlarged parathyroid 
glands was only 70%  [8]. 
In renal HPT, parathyroidectomy may reduce bone pain and pruritus. In pHPT, bilateral neck exploration is 
associated with a cure rate in greater than 95% of patients, depending largely on the experience of the 
surgeon.Despite intraoperative measurement of intact parathyroid hormone (PTH) and excellent surgical results 
in experienced centers, there are still a certain number of patients who will require reoperation due to persistent 
or recurrent HPT after primary surgery [9]. 
These operations are technically challenging due to distortion and scarring in tissue planes after previous 
cervical operation, with a markedly higher complication rate and risk for injury of the recurrent laryngeal nerve. 
Localizing the remaining hyperfunctioning parathyroid glands in patients with previous cervical operations is 
helpful in minimizing surgical effort and complication rates during reoperation. 
4. Conclusion 
However, noninvasive methods, such as ultrasound, sestamibi scan or MRI, are not always successful in 
localizing the hyperfunctioning parathyroid gland. Selective venous sampling (SVS) of PTH is an invasive 
method of localization that is used only rarely in comparison to noninvasive methods.   Ultrasonography is an 
important, cost-effective diagnostic tool that is frequently used in combination with a sestamibi scan. 
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